2010 key highlights
2010 Revenues and other operating income
(€ million)
105+ mln
Vaccine doses distributed in 2010
In more than 100 countries around the world.
€100.0 mln
Research and development investment in 2010
2010 Product sales
(€290.6 million)
€290.6 mln
Product sales in 2010
€365.4 mln
Total revenues and other operating income in 2010
Compared to €358.0 mln in 2009.